- Lobbying
- Lobbying by Pfizer Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Ludmila Zawistowich | Executive Director, MACPAC; Deputy Director, MedPAC |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Termination
Q2 Report
Lobbying Issues
Agencies Lobbied
Medicare Payment Advisory Commission (MedPAC)
Type of Issue
Q1 Report
Lobbying Issues
Agencies Lobbied
Medicare Payment Advisory Commission (MedPAC)
Type of Issue
Registration
Issue(s) they said they’d lobby about: Issues related to the value of pharmaceuticals including developing sustainable models that support innovation..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate